Phibro Animal HealthPAHC
About: Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Employees: 1,940
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
88% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 16
6% more funds holding
Funds holding: 172 [Q4 2024] → 183 (+11) [Q1 2025]
1% less capital invested
Capital invested by funds: $436M [Q4 2024] → $434M (-$2.37M) [Q1 2025]
7% less repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 68
2.52% less ownership
Funds ownership: 102.07% [Q4 2024] → 99.55% (-2.52%) [Q1 2025]
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2K
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
2 analyst ratings
JP Morgan Ekaterina Knyazkova | 14%upside $35 | Overweight Upgraded | 7 Jul 2025 |
Morgan Stanley Erin Wright | 16%downside $26 | Equal-Weight Maintained | 25 Jun 2025 |
Financial journalist opinion
Based on 19 articles about PAHC published over the past 30 days
